Dr. Leslie Miller

Chief Medical Officer Dr. Leslie Miller

Dr. Leslie Miller serves as the Chief Medical Officer at Second Heart Assist, Inc. In this role, Dr. Miller oversees the company's medical strategies, ensuring the development and implementation of innovative medical devices aimed at treating heart failure. The position involves leading clinical research, managing healthcare compliance, and collaborating with other executives to drive clinical success. Dr. Miller's leadership is pivotal in maintaining the quality and safety of the company’s medical products.

Board Director Dr. Leslie Miller

In addition to being the Chief Medical Officer, Dr. Leslie Miller holds a position on the board of directors at Second Heart Assist, Inc. As a board director, Dr. Miller contributes to the strategic planning and governance of the company. This role involves guiding the company’s vision, ensuring regulatory adherence, and participating in critical decision-making processes. Dr. Miller’s dual leadership roles underscore a profound commitment to the organization's growth and mission.

Presentation at Annual Devices for Heart Failure Meeting

Dr. Leslie Miller presented on behalf of Second Heart Assist, Inc. at the Annual Devices for Heart Failure Meeting. This presentation highlighted the company’s advancements and contributions to heart failure treatments. Dr. Miller’s insights and expertise showcased the effectiveness and promise of the company's medical devices, gaining recognition from peers and industry leaders. The presentation demonstrated the commitment to addressing heart failure through innovative technologies.

MedTech Outlook Magazine Feature: Top MedTech Innovations of 2021

Dr. Leslie Miller was featured on the cover of MedTech Outlook Magazine as one of the top MedTech innovations of 2021. This recognition was a testament to Dr. Miller's contributions to the medical technology field and the innovative work done at Second Heart Assist, Inc. The feature highlighted impactful advancements and Dr. Miller's role in leading these developments, contributing significantly to the field of heart failure treatment.